Home Global Why Merck Crushed the Market Today

Why Merck Crushed the Market Today

0
Why Merck Crushed the Market Today

Published

What happened

Merck (NYSE: MRK) stock was the very picture of health on Thursday. Investors were pleased with the first quarter earnings report, which saw a huge price increase for this large pharmaceutical company.

So what

Merck revealed that it took in $15.9 billion in sales for the period, a robust 50% higher on a year-over-year basis. Non-GAAP (adjusted) net income swelled even more, rising 84% to over $5.4 billion, or $2. 14 per share.

Medical professional holding a dollar sign paperweight.

Image source: Getty Images.

Both were significantly higher than the typical analyst estimate. Prognosticators tracking Merck stock had been modeling barely over $14.7 billion on the top line and $1. 83 in adjusted, per-share net profit.

Merck’s CEO Robert Davis stated in the earnings release that “robust” quarter results were due to significant clinical advances in Merck’s research pipeline, and efficient commercial execution across many key growth drivers. “

Now what

Davis added that they remain focused on driving their strategy which is based in science and believe in the viability of our growth prospects. “

Merck believes that this is a sign of better-than-expected growth. It has raised and tightened its guidance for both revenue and profitability for the entirety of 2022.

The new projection for sales for the year is $56.9 billion to $58.1 billion. If achieved, it would mean at least a 17% improvement over the 2021 figure. They should be at $7 for per-share adjusted earnings. 24 to $7. 36, which is a minimum of 20% above last year’s $6.02.

10 stocks we like better than Merck & Co.
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market. *

They just revealed what they believe are the ten best stocks for investors to buy right now… and Merck & Co. wasn’t one of them! That’s right — they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of April 7, 2022

Eric Volkman has no position in any of the stocks mentioned. None of these stocks are held by The Motley Fool. The Motley Fool has a disclosure policy.

The views and opinions expressed in this article are those of the author, and not necessarily the views of Nasdaq, Inc .

The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world’s greatest investment community. Through its newsletter, website, newspapers, column, radio and television broadcasts, millions are reached each month by The Motley Fool. It advocates for individual investors and champions shareholder value. Shakespeare inspired the company name. Shakespeare’s wise, amusing fools could both instruct and laugh and were able to tell the truth without having their heads cut off.

Learn More

LEAVE A REPLY

Please enter your comment!
Please enter your name here